| Financial Year |
March 31 2023 |
| Monetary Funds |
2,203,616,157.25 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
77,138,663.74 |
| Accounts Receivable |
1,153,547,254.72 |
| Advances to Suppliers |
730,198,638.29 |
| Other Receivables |
23,308,330.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,584,700,968.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
69,451,850.32 |
| Total Current Assets |
5,878,928,865.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
38,601,170.27 |
| Investment Properties |
86,573,142.91 |
| Fixed Assetes |
2,532,705,368.89 |
| Under-construction Projects |
200,741,628.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
458,322,847.42 |
| R&D expenses |
-- |
| Goodwill |
46,669,275.37 |
| Long-Term Deferred and Prepaid Expenses |
9,304,387.41 |
| Deferred Income Tax Assets |
126,719,807.40 |
| Other Non-Current Assets |
133,302,820.03 |
| Sub-Total of Non-Current Assets |
3,671,556,640.16 |
| Total Assets |
9,550,485,505.58 |
| Short-Term Loans |
130,018,694.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,837,961,938.76 |
| Accounts Payable |
537,992,831.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
89,583,684.15 |
| Taxes Payable |
77,361,215.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
282,251,322.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,761,607.87 |
| Other Current Liabilities |
119,578,715.69 |
| Sub-Total of Current Liabilities |
4,059,605,133.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
72,237,137.54 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
44,994,031.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
321,039,420.34 |
| Total Liabilities |
4,380,644,553.44 |
| Paid-In Capital(Or Share Stock) |
1,229,093,871.00 |
| Capital Surplus |
1,132,645,965.97 |
| Surplus Reserve |
372,531,449.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,356,470,590.38 |
| Minority Stockholder's Interest |
66,854,660.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,102,986,292.11 |
| Owner's Equity（Stockholder's Equity） |
5,169,840,952.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,550,485,505.58 |
